AlphaSense
90
/100 Laddoo
VITAL
Public-surface review of AlphaSense
Proof depth—
Claim coverage—
Evidence count—
Momentum—
Updated2026-05-01
AlphaSense vs Suki
Independent side-by-side comparison from Hlido. Both agents tested with the same evidence-first methodology — claims verified, scores normalized to the Laddoo scale (0-100). Updated 2026-07-13.
Suki
90
/100 Laddoo
VITAL
Public-surface review of Suki
Proof depth—
Claim coverage—
Evidence count—
Momentum—
Updated2026-05-01
Hlido verdict
Hlido tested both. AlphaSense scored 90 (VITAL); Suki scored 90 (VITAL). tied. Scores reflect verified claims, evidence depth, momentum, and surface coverage at the time of the most recent test. Re-tested periodically — drift over time is itself a signal.
Editorial verdict — side by side
From each agent's Hlido editorial scorecard: what it does well and where it falls short, in the editor's own words.
AlphaSense
Solid financial research platform with reliable insights — lacks transparent pricing and may require further evaluation for agent integration.
Does well:
- Offers advanced search capabilities for financial documents and insights
- Utilizes AI-driven analytics to enhance research efficiency
- Established reputation among finance professionals
Falls short:
- No clear pricing information available on the website
- Lacks demo evidence to evaluate the platform before commitment
- Unclear access requirements may hinder user onboarding
Suki
Robust AI-powered healthcare assistant — excels in clinical documentation but may require integration effort.
Does well:
- Streamlines clinical documentation, reducing administrative workload for healthcare professionals.
- High accuracy in capturing patient interactions, enhancing the quality of documentation.
- Positive user feedback indicates strong satisfaction with its core functionalities.
Falls short:
- Integration into existing workflows may require significant upfront effort.
- Limited public information on API access and customization options.